Почетна › Рак панкреаса › Alabama
Kliničke studije za Рак панкреаса u državi Alabama
13 studija za Рак панкреаса traži učesnike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Zvanični tekst studije (na engleskom)
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US058, Birmingham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07522073Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Clearview Cancer Institute, Huntsville
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07562152INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
- University of Alabama at Birmingham, Birmingham
Тражи се учесникНаводи исплату за учеснике
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07671937A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- The University of Alabama at Birmingham, Birmingham
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07252232A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06989437DESTINY-PANTUMOUR04
- Research Site, Birmingham
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach
- University of Alabama at Birmingham, Birmingham
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT05764720Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- University of Alabama at Birmingham Cancer Center, Birmingham
- University of South Alabama Mitchell Cancer Institute, Mobile
Тражи се учесникОпсервациона студија
Узраст од 50 до 75 · Оба пола · Ажурирано 4. 9. 2026. · NCT04239573Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT05297734A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Birmingham
- Ohio State University-Telemedicine, Mobile
- Ohio State University Telemedicine, Montgomery
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 17. 2. 2026. · NCT06906562SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
- University of Alabama Birmingham, Birmingham
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 25. 2. 2025. · NCT02674100Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.